It might be that some of the simplistic theories as to how EDTA achieved its results may have prevented some scientists and physicians from taking it seriously or of investigating its potential. The current theories as to how calcium is encouraged to leave atheromatous deposits in blocked arteries have been well investigated by the proponents of chelation therapy and deserve to be seriously considered in view of the vast amount of illness attached to this area of human suffering and the remarkable results demonstrated by chelation physicians.

Bypass surgery and drug treatment of the conditions which chelation so often effectively deals with are very big business indeed. In the USA alone, $4 billion is the current turnover per annum of the bypass industry. A lesser, but nevertheless enormous, sum is involved in medication for conditions which the relatively cheap (and now out of patent) substance EDTA can be shown to help. Such vested interests should not be underestimated when it comes to the lengths to which they will go to try to discredit methods which threaten their stranglehold on the 'market' Chelation therapy continues to grow, however, as public awareness and knowledge increases of this safe alternative to surgery and drugs, many of which are of questionable safety and value.